PIK3C3 and non-small cell lung carcinoma: The numbers of living cells at day 2 were reduced with the combination as compared to treatment with Ceritinib or VPS34-IN1 alone (Fig. 3A), suggesting that Ceritinib-induced autophagy plays a cytoprotective role in NSCLC cells.